Labcorp unveils new name for future independent clinical development business - fortrea

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its clinical development business will be known as fortrea. upon completion of the spin-off from labcorp, fortrea will operate as an independent, publicly traded global cro that offers comprehensive drug and medical device development services.
LH Ratings Summary
LH Quant Ranking